[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:human-papillomavirus-independent-cervical-adenocarcinoma-clear-cell-type":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":21,"states":22},"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06730347","A Study of Lorigerlimab in Participants With Advanced Solid Tumors",[11],"Phase 2","RECRUITING","2026-08-26T02:17:09.131534Z","2026-06-18T04:29:21.275392Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05046080","Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix",[],"2026-08-26T02:17:13.277148Z","2026-05-13T02:55:06.279545Z",[],[]]